These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients]. Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237 [TBL] [Abstract][Full Text] [Related]
3. [Countermeasure for patients with anemia due to hemodialysis]. Suzuki M Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721 [No Abstract] [Full Text] [Related]
4. Recombinant erythropoietin for the anemia of chronic renal failure. Ahmad R; Hand M N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706 [No Abstract] [Full Text] [Related]
5. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis]. von Appen K; Klinkmann H Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771 [No Abstract] [Full Text] [Related]
6. Erythropoietin for anemia of renal failure in sickle cell disease. Steinberg MH N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999 [No Abstract] [Full Text] [Related]
7. Treatment of renal anemia with recombinant erythropoietin. International workshop. Wolfenbüttle, November 22-24, 1987. Proceedings. Contrib Nephrol; 1988; 66():1-211. PubMed ID: 3391026 [No Abstract] [Full Text] [Related]
8. [The after effect of r-HuEPO in treating anemic hemodialysis patients]. Chu JQ Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758 [No Abstract] [Full Text] [Related]
9. [Complications of long-term hemodialysis patients and the countermeasures]. Asano Y Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1273-8. PubMed ID: 1431471 [No Abstract] [Full Text] [Related]
10. [Dialysis-associated heart failure and the prevention and therapy]. Nishi S; Hirasawa Y Nihon Rinsho; 1992 Jan; 50 Suppl():695-9. PubMed ID: 1578753 [No Abstract] [Full Text] [Related]
11. [Treatment of renal anemia using human erythropoietin]. Zehnder C; Blumberg A Dtsch Med Wochenschr; 1987 Jun; 112(23):938-9. PubMed ID: 3582205 [No Abstract] [Full Text] [Related]
12. The KDIGO anemia guideline: can reason triumph over regulation? Wish JB Nephrol News Issues; 2012 Dec; 26(13):20, 22-3. PubMed ID: 23346853 [No Abstract] [Full Text] [Related]
13. [The abnormalities of blood cells in chronic kidney failure with long-term dialysis]. Narita M; Shibata A Nihon Rinsho; 1992 Jan; 50 Suppl():763-70. PubMed ID: 1578764 [No Abstract] [Full Text] [Related]
14. Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis. Maurin N; Fitzner S; Fritz H; Gladziwa U; H agel J; Stefanidis I Clin Nephrol; 1995 Mar; 43(3):196-200. PubMed ID: 7774078 [TBL] [Abstract][Full Text] [Related]
15. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin]. Schaefer RM Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139 [No Abstract] [Full Text] [Related]
16. [Treatment of anemia in chronically dialyzed patients]. Moynot A Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055 [No Abstract] [Full Text] [Related]
17. [Diagnosis and therapy of renal anemia]. Hara S Nihon Naika Gakkai Zasshi; 1999 Jun; 88(6):1029-34. PubMed ID: 10465946 [No Abstract] [Full Text] [Related]